CompletedNCT05300425
Seroprevalence of Leptospirosis in Val Müstair, Switzerland
Studying Leptospirosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital, Basel, Switzerland
- Principal Investigator
- Michael Osthoff, PD Dr. med.University Hospital Basel, Division of Internal Medicine
- Intervention
- Blood sample collection(other)
- Enrollment
- 258 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2022 – 2024
Study locations (2)
- University Hospital Basel, Division of Internal Medicine, Basel, Switzerland
- Center da sanda Val Muestair, Val Müstair, Switzerland
Collaborators
Cantonal Hospital of St. Gallen
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05300425 on ClinicalTrials.govOther trials for Leptospirosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07127718Preventive Strategies for Early and Late Complications of LeptospirosisNational Kidney and Transplant Institute, Philippines
- RECRUITINGNANCT05436756Chronic Post-leptospirosis Manifestations in ReunionCentre Hospitalier Universitaire de la Réunion
- ACTIVE NOT RECRUITINGNANCT04034550Cohort of Hospitalized Patients Suspected of LeptospirosisInstitut National de la Santé Et de la Recherche Médicale, France
- RECRUITINGNCT04288674Leptospirosis Registry - LeptoScopeUniversity of Cologne
- RECRUITINGNANCT05425524Leptospirosis Care Bundle StudyChulalongkorn University